( en | de | ru )

 

Disambiguation of "Thabane, Lehana"

Author of the publication

copydeleteadd this publication to your clipboard
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study.

, , , , , , , , and . PloS one, 6 (10): e25491 (January 2011)6400<m:linebreak></m:linebreak>JID: 101285081; 2011/02/24 received; 2011/09/06 accepted; 2011/10/18 epublish; ppublish;.
DOI: 10.1371/journal.pone.0025491

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Thabane, Lehana
add a person with the name Thabane, Lehana
 

Other publications of authors with the same name

An introduction to multiplicity issues in clinical trials: the what, why, when and how., , , , , , , and . International journal of epidemiology, 46 (2): 746-755 (April 2017)Comparacions múltiples; RCT.Effect of Early Treatment with Ivermectin among Patients with Covid-19, , , , , , , , , and 17 other author(s). New England Journal of Medicine, 386 (18): 1721-1731 (05 May 2022 2022)Tips on overlapping confidence intervals and univariate linear models., , and . Nurse researcher, 16 (4): 73-83 (January 2009)5328<m:linebreak></m:linebreak>JID: 9435953; RF: 15; ppublish;<m:linebreak></m:linebreak>Límits de confiança; Mesures de contrast.Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest., , , and . Journal of clinical epidemiology, (October 2019)Anàlisi de dades; Risc relatiu vs absolut.Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group., , , , , , , , , and 1 other author(s). Trials, (January 2011)6243<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101263253; OID: NLM: PMC3049182; 2010/11/14 received; 2011/02/18 accepted; 2011/02/18 aheadofprint; epublish;<m:linebreak></m:linebreak>Recursos/Organització; Consulting.Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?, , , , , , , , , and 4 other author(s). Journal of Clinical Epidemiology, (December 2016)Prophylaxis for covid-19: living systematic review and network meta-analysis, , , , , , , , , and 30 other author(s). medRxiv, (February 2021)Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials., , and . BMC medical research methodology, (January 2010)6222<m:linebreak></m:linebreak>LR: 20100928; JID: 100968545; OID: NLM: PMC2834676; 2009/04/25 received; 2010/02/05 accepted; 2010/02/05 aheadofprint; epublish;<m:linebreak></m:linebreak>Disseny; RCT; Publicació.Guidelines for Reporting Outcomes in Trial Reports, , , , , , , , , and 16 other author(s). 328 (22): 2252 (2022)Framing of research question using the PICOT format in randomised controlled trials of venous ulcer disease: a protocol for a systematic survey of the literature, , , , and . BMJ Open, (Oct 2, 2016)